• Home
  • Technology
    • Gelrin Technology and Status
    • Patents
    • Market, Competition and Opportunity
    • Videos
  • Investors
  • Contact Us
Regentis Biomaterials Logo
Regentis Biomaterials Logo
  • HOME
  • TECHNOLOGY
    • Gelrin Technology and Status
    • Patents
    • Market, Competition and Opportunity
    • Videos
  • INVESTORS
  • CONTACT US

Investor Relations

Committee Composition

☰  IR MENU
  • Overview
  • Press Releases
  • SEC Filings
  • Stock Info
    • Stock Chart
    • Historical Stock Quote
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Scientific Advisory Board
    • Management
    • Board of Directors
    • Committee Composition
    • Documents
  • Resources
    • Contact IR
    • Email Alerts
  • Overview
  • Press Releases
  • SEC Filings
  • Stock Info
    • Stock Chart
    • Historical Stock Quote
    • Analyst Coverage
  • Events & Presentations
  • Governance
    • Scientific Advisory Board
    • Management
    • Board of Directors
    • Committee Composition
    • Documents
  • Resources
    • Contact IR
    • Email Alerts
Committee Audit Compensation
Keith Valentine icon of chairmember icon of member
Pini Ben Elazar icon of member icon of member
Efraim Cohen-Arazi icon of member icon of chairmember
Chairman Icon

Chairman
Member Icon

Member

Security holders may request a hard copy of Regentis’s Annual Report, including its complete audited consolidated financial statements, free of charge, to its shareholders upon request to Regentis Investor Relations at 60 Medinat Hayehudim Street, 4676652, Israel or by phone at +972 (9) 960-1917. 

© 2026 Regentis Biomaterials. All Rights Reserved
|
Terms of Use
|
Privacy Policy
|
Accessibility Declaration
|
Sitemap
|
Powevered by ACCESS Newswire
Share by: